Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell sequencing reveals the landscape of the tumor microenvironment in a skeletal undifferentiated pleomorphic sarcoma patient. | Front Immunol | 2022 | 36466840 | PubTator, text mining | PubMed |
| Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type. | Aging Dis | 2022 | 36465169 | PubTator, text mining | PubMed |
| Occurrence of acute kidney injury in adult patients hospitalized with COVID-19: A systematic review and meta-analysis. | Nefrologia (Engl Ed) | 2022 | 36460430 | PubTator, text mining | PubMed |
| Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancer. | Nature | 2022 | 36450981 | PubTator, text mining | PubMed |
| Characterization of genomic alterations and neoantigens and analysis of immune infiltration identified therapeutic and prognostic biomarkers in adenocarcinoma at the gastroesophageal junction. | Front Oncol | 2022 | 36439494 | PubTator, text mining | PubMed |
| Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy. | Front Immunol | 2022 | 36439144 | PubTator, text mining | PubMed |
| Single-cell transcriptomic characterization reveals the landscape of airway remodeling and inflammation in a cynomolgus monkey model of asthma. | Front Immunol | 2022 | 36439114 | PubTator, text mining | PubMed |
| Identification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells. | Front Genet | 2022 | 36437952 | PubTator, text mining | PubMed |
| Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. | Exp Mol Med | 2022 | 36434043 | PubTator, text mining | PubMed |
| Expression and regulatory characteristics of peripheral blood immune cells in primary Sjögren's syndrome patients using single-cell transcriptomic. | iScience | 2022 | 36425764 | PubTator, text mining | PubMed |
| Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer. | Cancer Cell | 2022 | 36423636 | PubTator, text mining | PubMed |
| A SERPINE1-Based Immune Gene Signature Predicts Prognosis and Immunotherapy Response in Gastric Cancer. | Pharmaceuticals (Basel) | 2022 | 36422531 | PubTator, text mining | PubMed |
| Genetic mutation and tumor microbiota determine heterogenicity of tumor immune signature: Evidence from gastric and colorectal synchronous cancers. | Front Immunol | 2022 | 36420271 | PubTator, text mining | PubMed |
| Systematic single-cell pathway analysis to characterize early T cell activation. | Cell Rep | 2022 | 36417885 | PubTator, text mining | PubMed |
| Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection. | Biochem Mosc Suppl B Biomed Chem | 2022 | 36407837 | PubTator, text mining | PubMed |
| Alzheimer's disease alters the transcriptomic profile of natural killer cells at single-cell resolution. | Front Immunol | 2022 | 36405736 | PubTator, text mining | PubMed |
| Combined use of lactoferrin and vitamin D as a preventive and therapeutic supplement for SARS-CoV-2 infection: Current evidence. | World J Clin Cases | 2022 | 36405280 | PubTator, text mining | PubMed |
| Somatic 9p24.1 alterations in HPV- head and neck squamous cancer dictate immune microenvironment and anti-PD-1 checkpoint inhibitor activity. | Proc Natl Acad Sci U S A | 2022 | 36395141 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancer. | Front Oncol | 2022 | 36387163 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=49